Clinical Trials Browser

Menorrhagia × 1 year × Clear all

Uterine Anomalies, Dysmenorrhea, Dyspareunia, Infertility, Menorrhagia, Metrorrhagia, Myoma, Abdominal Pain, Adenomyoma, Hemostatic Disorders, Adenomyosis

NCT06671548 2026-02-02

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Phase 3 Recruiting

120 enrolled

Leiomyoma, Menorrhagia

NCT07378098 2026-01-30

to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia

Phase 3 Recruiting

254 enrolled

Leiomyoma, Menorrhagia

NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Phase NA Completed

114 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT05538689 2025-09-29

SOUL

Phase 4 Withdrawn

Leiomyoma, Menorrhagia, Metrorrhagia, Pelvic Pain

NCT06058728 2025-09-17

Pink Orchid

Withdrawn

Leiomyoma, Menorrhagia

NCT03271489 2025-07-22

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Phase 3 Completed

478 enrolled 9 charts

Leiomyoma, Menorrhagia

Clinical Trials

MUSA3

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia

Post Market TRUST - U.S.A. Study

SOUL

Pink Orchid

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women